Market Cap	183 158.06 145.65 136.34 255.5 17.39T 259.46 1.72T 670.53 8.47T 686.8 672.18 29.31T	P/E Ratio 2021	-8.24x	P/E Ratio 2022	-7.54x
Enterprise Value	-4.96Cr -4.28Cr -3.94Cr -3.69Cr -6.92Cr -471.03Cr -7.03Cr -47Cr -18Cr -229.27Cr -19Cr -18Cr -793.84Cr	EV / Sales 2021	11.8x	EV / Sales 2022	7.47x
Free-Float	100%	Yield 2021 *	-	Yield 2022	-

Chart: ViewRay Systems, Inc.

Timeframe

Style

Latest news : ViewRay Systems, Inc.

12/01	Outset Medical, Inc. Announces Board Changes	CI
03/12	Cowealth Medical China Unit to Sell Therapy System to Connected Party in Taiwan	MT
12/24/12	Cowealth Medical China Gets Business Authorization for ViewRay Systems' Products	MT
26/23/26	Motion For Case Conversion Approved for ViewRay, Inc.	CI
12/23/12	Motion for Case Conversion Filed by ViewRay, Inc.	CI
29/23/29	Final DIP Financing Approved for ViewRay, Inc.	CI
23/23/23	Bidding Procedure Approved for ViewRay, Inc.	CI
04/23/04	On August 3, 2023, Viewray, Inc. Relocates Its Headquarters to Oakwood Village, Ohio	CI
25/23/25	ViewRay, Inc.(OTCPK:VRAY.Q) dropped from NASDAQ Composite Index	CI
22/23/22	ViewRay to be Delisted From Nasdaq July 26	MT
22/23/22	Insider Sell: Viewray	MT
22/23/22	ViewRay, Inc. Announces the Resignation of Sai Nanduri as Observer to the Board	CI
21/23/21	Motion for Asset Sale Filed by ViewRay, Inc.	CI

11/23/11	Morgan Stanley Adjusts ViewRay's Price Target to $1 From $2, Keeps Equalweight Rating	MT
11/23/11	B. Riley Downgrades ViewRay to Neutral From Buy, Notes More Cautious, Conservative 2023 Outlook; Trims PT to $1 From $4	MT
24/23/24	Piper Sandler Cuts Price Target on ViewRay to $2 From $6.50, Maintains Overweight Rating	MT
17/23/17	Jefferies Downgrades ViewRay to Hold From Buy, Cuts Price Target to $1.25 From $7	MT
14/23/14	Oppenheimer Downgrades ViewRay to Perform Rating From Outperform	MT

16/23/16	TeamBest Global Companies - Open Letter to ViewRay Customers From Krishnan Suthanthiran, President/Founder of TeamBest Global Companies	AQ
22/23/22	ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets	PR
17/23/17	ViewRay® Files Voluntary Chapter 11 Petitions	PR
01/23/01	ViewRay : Failure to Satisfy Listing Rule - Form 8-K	PU
13/23/13	VA Oklahoma City Healthcare System Chooses ViewRay's MRIdian® MRI-Guided Radiation Therapy System	PR

Manager	Title	Age	Since
Samantha Pfeil SAM	Sales & Marketing	-	01/04/2021
Amanda Sequira LAW	General Counsel	49	01/10/2018

Date	Insider	Type	Main position	Quantity	% Market Cap.
21/23/21	B. Johnson	Sell	Director	30,702	0.0167%
19/23/19	Kearny Venture Partners	Sell	Company	15,45,600	0.8427%
19/23/19	Paul Ziegler	Sell	Chief Executive Officer	1,69,785	0.0926%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VIEWRAY SYSTEMS, INC.	0.00%	0.00%	-	-	183
FACTORIAL ENERGY INC.	-11.23%	+28.82%	-	-	140.29Cr
EINRIDE AB	-10.83%	0.00%	-	-	131.5Cr
AIR GLOBAL PLC	-1.43%	-0.14%	-	-	126.05Cr
CENTIEL AG	+8.96%	+36.19%	+329.41%	-64.90%	75Cr
ACC AVIATION HOLDINGS LTD.	-9.15%	+72.00%	+1,190.00%	+303.12%	64Cr
CANTOR EQUITY PARTNERS IV, INC.	-0.19%	+0.19%	-	-	59Cr
CHURCHILL CAPITAL CORP XI	-0.68%	-0.68%	-	-	57Cr
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	-0.35%	-0.09%	-	-	56Cr
Average	-2.77%	+13.39%	+759.71%	+119.11%	78.74Cr
Weighted average by Cap.	-4.47%	+12.83%	+727.31%	+105.26%

	2021	2022
Net sales	7.01Cr 6.06Cr 5.58Cr 5.22Cr 9.79Cr 666.49Cr 9.94Cr 66Cr 26Cr 324.4Cr 26Cr 26Cr 1.12TCr	10Cr 8.83Cr 8.13Cr 7.61Cr 14Cr 971.47Cr 14Cr 96Cr 37Cr 472.85Cr 38Cr 38Cr 1.64TCr
Net income	-11Cr -9.5Cr -8.76Cr -8.2Cr -15Cr -1.05TCr -16Cr -103.42Cr -40Cr -509.13Cr -41Cr -40Cr -1.76TCr	-11Cr -9.27Cr -8.54Cr -8Cr -15Cr -1.02TCr -15Cr -100.87Cr -39Cr -496.56Cr -40Cr -39Cr -1.72TCr
Net Debt	-15Cr -13Cr -12Cr -11Cr -21Cr -1.43TCr -21Cr -141.41Cr -55Cr -696.14Cr -56Cr -55Cr -2.41TCr	-4.96Cr -4.28Cr -3.94Cr -3.69Cr -6.92Cr -471.03Cr -7.03Cr -47Cr -18Cr -229.27Cr -19Cr -18Cr -793.84Cr